In gynecologic cancers, common genes regulated by prognosis-alternative miRNAs such as BCL2, EGFR, PDGFRA, and VEGFA were also demonstrated to be combinational targets for anti-cancer drugs. The gene discussed is BCL2; the disease is cancer.